Blue Goat CyberBlue Goat CyberSMMedical Device Cybersecurity
    Start here
    Services
    • Medical Device Cybersecurity Consulting
    • FDA Premarket Cybersecurity Package
    • Medical Device Penetration Testing Services
    • FDA Deficiency Response
    • FDA Postmarket Cybersecurity
    • Medical Device Threat Modeling
    • eSTAR Cybersecurity Documentation Support
    See all services
    Products

    Blue Goat products

    • GoatWatch logoGoatWatchSBOM risk management for medical devices
    About
    Resources

    Learn

    • Blog
    • Podcast
    • Webinars
    • Talks & workshops
    • Glossary
    • FAQs

    Playbooks & Tools

    • Guides
    • Playbooks (PDF)
    • Infographics
    • Interactive Tools

    Signals & Proof

    • Goat FeedNew
    • News
    • Medical Device Security News
    • The Goat's Weekly
    • Case Studies
    • Proof / Receipts
    All resources, topic hubs, & collections →
    ⌘K
    Book Strategy SessionHow to prepare →
    Blue Goat Cyber

    Full-service medical device cybersecurity. We protect patients by securing connected medical devices from design through postmarket.

    275+ FDA submissions supported, zero cybersecurity rejections · Mission: 1,000 by 2028

    SDVOSB · Service-Disabled Veteran-Owned Small Business

    We sponsor 10 community projects →

    Services

    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing Services
    • FDA Postmarket Cybersecurity
    • All services →
    Services
    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing Services
    • FDA Postmarket Cybersecurity
    • All services →

    Company

    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF
    Company
    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF

    Resources

    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →
    Resources
    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →

    Get in touch

    • info@bluegoatcyber.com
    • 844-939-GOAT
    • Book a strategy session →
    • 1776 N Scottsdale Rd, Unit 727
      Scottsdale, AZ 85257Serving clients worldwide

    Follow

    © 2026 Blue Goat Cyber. All rights reserved.

    • Privacy
    • Terms
    • Cookies
    • Sitemap
    • Accessibility
    • CVD

    MedTech Cybersecurity · Since 2022

    CVD policy in 4 minutes

    Coordinated Vulnerability Disclosure Generator

    For cyber devices on covered submission pathways, Section 524B requires a plan including coordinated vulnerability disclosure. Generate a draft for manufacturer and legal review.

    Christian Espinosa, Founder & CEO, Blue Goat Cyber

    Reviewed by

    Christian Espinosa

    Founder & CEO, Blue Goat Cyber

    Last reviewed November 3, 2026

    What you'll see after you submit

    Draft CVD policy and illustrative company targets

    • MilestoneTimeline infographic: acknowledgement → triage → fix → public disclosure SLAs.
    • ISO/IEC 29147-structured policy text with your contact details and PGP fingerprint baked in.
    • Copy-to-clipboard handoff for legal review and posting at /security or /.well-known/security.txt.
    • Direct alignment notes for FDA §524B 'coordinated vulnerability disclosure process' requirement.

    Common misconceptions

    What teams usually get wrong

    • Myth: A security@ inbox is enough to satisfy FDA's CVD requirement.

      Reality: For covered cyber-device submissions, the statutory plan includes coordinated vulnerability disclosure and related procedures. An inbox alone does not document intake, assessment, coordination, remediation, and communication. No fixed acknowledgement or triage SLA is universally prescribed.

    • Myth: We can wait until a researcher reports something to publish a policy.

      Reality: Provide applicable CVD plan evidence and the information requested by the FDA. This tool cannot predict whether or when the FDA will issue a deficiency.

    • Myth: Bug bounty = CVD program.

      Reality: Bounties pay for findings; CVD governs how findings are handled, disclosed, and reported to FDA. You can have CVD without a bounty, but not the other way around.

    • Myth: Safe-harbor language is boilerplate.

      Reality: Safe harbor is a substantive legal commitment. Have counsel approve its scope, terms, and authority before offering it.

    References & further reading

    Primary sources behind this tool

    1. 1ISO/IEC 29147:2018 - Vulnerability disclosure - ISO/IEC
    2. 2ISO/IEC 30111:2019 - Vulnerability handling processes - ISO/IEC
    3. 3CISA Coordinated Vulnerability Disclosure Process - CISA
    4. 4FDA Postmarket Management of Cybersecurity in Medical Devices (Dec 2016) - FDA
    5. 5security.txt - RFC 9116 - IETF
    Why this tool is current

    Recent regulatory + supply-chain activity

    Tracked signals that change what reviewers expect. Items move on as new ones land.

    • Jun 30, 2026EOS clock

      RHEL 7 Extended Life Support phase ends - devices on RHEL 7 need a compensating-controls memo

    • Feb 14, 2026Blue Goat research

      AI-letter analysis - 62% of FDA cyber deficiencies cite a missing or stale CVD URL

    • Oct 21, 2025CISA

      CISA Secure by Design pledge expanded with VEX publication expectation

    • Aug 5, 2025AAMI

      AAMI TIR97:2019 errata published - clarifies postmarket triage SLAs

    Operationalize CVD

    From policy to running program.

    Postmarket cybersecurity services

    Run a real CVD program with triage, remediation SLAs, and FDA reporting.

    Read Postmarket cybersecurity services

    Coordinated Vulnerability Disclosure page

    Our own CVD policy and security contact.

    Read Coordinated Vulnerability Disclosure page

    FDA premarket cybersecurity

    Complete §524B premarket package including CVD evidence.

    Read FDA premarket cybersecurity

    More tools

    PCCP, threat model starter, SBOM readiness.

    Read More tools